e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
iRhythm Technologies, Inc. - Common Stock
(NQ:
IRTC
)
178.57
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iRhythm Technologies, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
IRHYTHM TECHNOLOGIES, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. (NASDAQ: IRTC)
February 07, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IRTC
February 07, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
7 Healthcare Stocks Taking Medicine to the Next Level
↗
January 14, 2024
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Via
InvestorPlace
A Glimpse Into The Expert Outlook On iRhythm Technologies Through 6 Analysts
↗
January 08, 2024
Via
Benzinga
Analyst Expectations for iRhythm Technologies's Future
↗
December 12, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About iRhythm Technologies
↗
November 03, 2023
Via
Benzinga
Analyst Ratings for iRhythm Technologies
↗
October 11, 2023
Via
Benzinga
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
From
iRhythm
Via
GlobeNewswire
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
January 05, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
January 03, 2024
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services...
From
iRhythm
Via
GlobeNewswire
Analyst Ratings for iRhythm Technologies
↗
August 28, 2023
Via
Benzinga
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
November 13, 2023
Study findings from a collaboration with Duke Health found that a model that incorporates ECG data from long-term continuous monitoring resulted in more accurate prediction of heart failure...
From
iRhythm
Via
GlobeNewswire
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
September 26, 2023
From
iRhythm
Via
GlobeNewswire
Revolutionizing Tech: 7 Growth Stocks to Grab for Dynamic Returns
↗
August 23, 2023
For investors that want to position themselves for the future, these compelling top growth stocks to buy could be enticing.
Via
InvestorPlace
What 11 Analyst Ratings Have To Say About iRhythm Technologies
↗
July 11, 2023
Via
Benzinga
Citigroup Maintains Neutral Rating for iRhythm Technologies: Here's What You Need To Know
↗
June 07, 2023
Via
Benzinga
Analyst Expectations for iRhythm Technologies's Future
↗
June 07, 2023
Via
Benzinga
IRhythm Technologies' Cost Efficiency And Potential Entry Into The Japanese Market Earn Analyst Applaud
↗
August 07, 2023
Truist Securities analyst Richard Newitter reiterated a Buy rating on IRhythm Technologies, Inc. (NASDAQ: IRTC),
Via
Benzinga
Strong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter Manageable
↗
August 04, 2023
iRhythm Technologies Inc's (NASDAQ: IRTC) revenue of $124.1 million increased 21.6% Y/Y, beating the consensus of $120.3
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
↗
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
iRhythm Technologies' Market-Leading ZioService to Dominate ACM Sector: Analyst Initiates with Outperform Rating
↗
July 19, 2023
Baird initiated coverage on iRhythm Technologies Inc (NASDAQ: IRTC) with an Outperform rating and
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
July 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
↗
July 19, 2023
Via
Benzinga
7 Robotics Stocks to Target for Triple-Digit Returns in 2023
↗
June 28, 2023
Harness the power of robotics innovation for your portfolio and invest in these robotics stocks for high returns.
Via
InvestorPlace
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
June 21, 2023
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
Via
News Direct
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
↗
June 20, 2023
The Food and Drug Administration (FDA) has issued a warning to the heart monitoring company iRhythm (NASDAQ: IRTC), stating that its products include viol
Via
Benzinga
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into iRhythm Technologies, Inc. (IRTC)
June 16, 2023
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
Top 5 Health Care Stocks That Are Set To Fly In Q2
↗
June 09, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
↗
June 06, 2023
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.